Asahi Kasei Finechem Co., Ltd.November 14, 2025

FDA 483 - Asahi Kasei Finechem Co., Ltd. - November 14, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Asahi Kasei Finechem Co., Ltd.

Record Details

An FDA inspection of Asahi Kasei Finechem Co., Ltd. in Nobeoka, Japan, an API manufacturer, revealed a significant quality control issue. The firm failed to perform method validation studies on in-house developed test methods and method verification studies on USP methods used for finished product release testing. This deficiency compromises the firm's ability to ensure product quality and compliance with specifications.

Company: Asahi Kasei Finechem Co., Ltd.
Inspection Date: November 14, 2025
Product Type: Drugs
Office: Office of Inspections and Investigations
Person: Victoria Spivak (Pharmacist | Consumer Safety Officer)

Open in Dashboard

ID · 9195403b-6fee-4323-a607-c71d5c43e77d